Beta Bionics Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	Feb '26 Feb 27, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022
Market Capitalization	561	1,341	-	-	-
Enterprise Value	349	1,120	-	-	-
Last Close Price	12.63	30.47	-	-	-
PS Ratio	5.59	13.38	-	-	-
PB Ratio	1.95	4.66	-	-	-
P/TBV Ratio	1.95	4.66	-	-	-
EV/Sales Ratio	3.48	11.18	-	-	-
Debt / Equity Ratio	0.03	0.03	0.10	0.07	0.32
Net Debt / Equity Ratio	-0.74	-0.74	-1.27	-1.58	-1.81
Net Debt / EBITDA Ratio	3.02	3.02	2.18	2.67	0.37
Net Debt / FCF Ratio	3.77	3.77	1.86	2.82	0.39
Asset Turnover	0.42	0.42	0.50	0.17	-
Inventory Turnover	2.55	2.55	4.01	-	-
Quick Ratio	7.73	7.73	5.52	9.54	3.12
Current Ratio	8.66	8.66	6.29	9.77	3.21
Return on Equity (ROE)	-40.26%	-40.26%	-81.35%	-123.17%	-
Return on Assets (ROA)	-18.73%	-18.73%	-21.78%	-30.79%	-
Return on Capital Employed (ROCE)	-24.10%	-24.10%	-35.20%	-36.10%	-242.90%
Earnings Yield	-13.06%	-5.46%	-	-	-
FCF Yield	-10.03%	-4.19%	-	-	-
Buyback Yield / Dilution	-536.74%	-536.74%	-20.01%	-6.13%	-

Updated Feb 17, 2026. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q